Retail & Wholesale » Retail | McKesson Corp.

McKesson Corp. | Income Statement

Fiscal year is April-March. All values USD Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
137,609
179,045
190,884
198,533
208,357
214,319
Cost of Goods Sold (COGS) incl. D&A
129,571
168,116
179,941
187,845
197,965
203,557
Gross Income
8,038
10,929
10,943
10,688
10,392
10,762
SG&A Expense
5,388
7,398
7,092
7,331
7,471
7,684
EBIT
2,650
3,531
-
3,357
2,921
3,078
Unusual Expense
343
563
204
256
2,427
2,192
Non Operating Income/Expense
26
31
77
4,039
52
94
Interest Expense
257
374
353
308
283
264
Pretax Income
2,096
2,657
3,250
6,891
239
610
Income Tax
742
815
908
1,614
53
356
Consolidated Net Income
1,354
1,842
2,342
5,277
292
254
Net Income
1,359
1,775
2,290
5,194
62
33
Net Income After Extraordinaries
1,455
2,074
2,322
5,318
57
32
Net Income Available to Common
1,263
1,476
2,258
5,183
67
34
EPS (Basic)
5.42
6.28
9.69
22.74
0.32
0.17
Basic Shares Outstanding
229
232
230
221
208
196
EPS (Diluted)
5.42
6.28
9.69
22.74
0.32
0.17
Diluted Shares Outstanding
233
235
233
223
209
197
EBITDA
3,354
4,548
4,736
4,267
3,872
4,027
Non-Operating Interest Income
23
20
18
29
48
39
Minority Interest Expense
5
67
52
83
230
221
Equity in Affiliates (Pretax)
3
12
15
30
32
43

About McKesson

View Profile
Address
6555 State Highway 161
Irving Texas 75039
United States
Employees -
Website http://www.mckesson.com
Updated 07/08/2019
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the McKesson Distribution Solutions and McKesson Technology Solutions business segments. The McKesson Distribution Solutions segment istributes brand, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs and other healthcare-related products worldwide.